| Immuno-pet IMaging ResPonses AdministeRed Immune CheckpoiNt InhibiTor (NCT06218069) | Radboud University Medical Center | 2025-02-01 |
| A Prospective, Open-label, Single-arm Phase II Clinical Study of Fruquintinib Combined With S-1 for the Treatment of Metastatic Colorectal Cancer. (NCT06746545) | Fujian Cancer Hospital | 2025-02-01 |
| Mesenchymal Stem Cells Infusion in Patients With Autoimmune Diseases (NCT06888973) | National Institute of Blood and Marrow Transplant (NIBMT), Pakistan | 2025-02-01 |
| A Study of Direct Oral Anticoagulants in Patients with Painful Venous Malformations with Localized Intravascular Coagulation (NCT06729034) | Oslo University Hospital | 2025-02-01 |
| QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer (NCT06751277) | xiang yang | 2025-02-01 |
| "The Effect of Inhaled Nitroglycerin for COPD Patients (NCT06785337) | Beni-Suef University | 2025-02-01 |
| Various Procedural Treatment Options for Androgenetic Alopecia (NCT06826001) | Sheikh Zayed Medical College | 2025-02-01 |
| Use of Dapagliflozin in Primary Prevention of Cardiotoxicity of Anthracycline Chemotherapy in Breast Cancer Patients (NCT07245069) | University Medical Centre Ljubljana | 2025-02-01 |
| Study of QLC7401 in the Treatment of Primary Hypercholesterolemia or Mixed Hyperlipidemia With Elevated LDL Cholesterol (NCT06750341) | Qilu Pharmaceutical Co., Ltd. | 2025-02-01 |
| A Comparative Single Blind Clinical Study on the Effect of Alvogyl, Eugenol, and Nigella Sativa (Black Seed Oil) for Alveolar Osteitis. (NCT06823544) | HITEC-Institute of Medical Sciences | 2025-02-01 |
| Anti BCMA CAR- T Cell Therapy for Adults With Relapsed or Refractory Multiple Myeloma (NCT07477912) | Minsk Scientific-Practical Center for Surgery, Transplantation and Hematology | 2025-02-01 |
| Clinical Study on the Effectiveness and Safety of Lenvatinib As Adjuvant Treatment for Patients with High-risk Recurrence of Hepatocellular Carcinoma After Surgery (NCT06762782) | The First Affiliated Hospital with Nanjing Medical University | 2025-02-01 |
| Neoadjuvant Treatment of Triple-Negative Breast Cancer with Stereotactic Radiotherapy, PD-1 Monoclonal Antibody, and Chemotherapy (NCT06691594) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-02-01 |
| A Phase II Study of AK112 (PD1/VEGF Bispecific) in Combination with Chemotherapy in Patients with NSCLC (NCT06769295) | Sichuan University | 2025-02-01 |
| Phase II Trial of Albumin-Bound Paclitaxel Combined With Nedaplatin (TP) Via Hepatic Arterial Infusion for Advanced Breast Cancer Patients With Liver Metastases After Failure of Standard Therapy (NCT07284836) | Zhejiang Cancer Hospital | 2025-02-01 |
| Lot Consistency Study of COVID-19 and Influenza Combination Vaccine (NCT06482359) | Novavax | 2025-02-01 |
| Antibiotic Prophylaxis for Neurogenic Bladder Botox (NCT04791579) | University of Alberta | 2025-02-01 |
| Perioperative Music in Obese Patients Under Spinal Anesthesia (NCT06835101) | Asklepieion Voulas General Hospital | 2025-02-01 |
| A Study of Adebelimab Combined With Chemotherapy as a First-line Treatment Sequential Treatment for Extensive-stage Small Cell Lung Cancer (NCT06614621) | Fujian Cancer Hospital | 2025-02-01 |
| Semaglutide in Women With Polycystic Ovary Syndrome and Obesity (NCT06896981) | Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh | 2025-02-01 |
| CHiR Therapy for Elderly DLBCL Intolerant to Chemo (NCT06764017) | First Affiliated Hospital of Ningbo University | 2025-02-01 |
| A Phase Ib/II Clinical Study on the Application of Linperlisib Combined with the VRD Regimen in Newly Diagnosed Patients with Multiple Myeloma (NCT06799676) | Fuling Zhou | 2025-02-01 |
| Cyclosporine In Takotsubo Syndrome (NCT05946772) | University Hospital Heidelberg | 2025-02-01 |
| Phase II Study of Ivonescimab and Cadonilimab in Combination with Chemotherapy in Patients with ES-SCLC (NCT06769971) | Sichuan University | 2025-02-01 |
| A Study to Test Different Doses of BI 1584862 in People With a Distinct Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy (NCT06769048) | Boehringer Ingelheim | 2025-01-31 |
| A Clinical Study to Observe How Well That BAT8006 Works on Patients With Platinum Resistance Ovarian Cancer (NCT06545617) | Bio-Thera Solutions | 2025-01-31 |
| Preventive Effects of Silver Diamine Fluoride on Early Enamel Caries (NCT06797882) | National University of Malaysia | 2025-01-31 |
| Compare the Efficacy and Safety of Dabigatran and Enoxaparin in Patients With Portal Vein Thrombosis With Cirrhosis (NCT06818279) | Institute of Liver and Biliary Sciences, India | 2025-01-31 |
| A Phase II Study of SYHA1813 for Recurrent or Progressive High-Grade Meningioma (NCT06739213) | Shanghai Runshi Pharmaceutical Technology Co., Ltd | 2025-01-31 |
| Phase I/II Study of a Combination of Decitabine and Cedazuridine (ASTX727) and ASTX029, an ERK Inhibitor, for Patients With RAS Pathway Mutant Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms (NCT06284460) | M.D. Anderson Cancer Center | 2025-01-31 |
| A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex) (NCT06514794) | Allotera Therapeutics | 2025-01-31 |
| The ENABLE Study: Safety and Efficacy Study of INZ-701 in Patients With ENPP1 Deficiency (NCT06739980) | Inozyme Pharma | 2025-01-31 |
| Efficacy of Montelukast in Preventing Transaminase Elevation in Adult Dengue Patients (NCT06747130) | Phramongkutklao College of Medicine and Hospital | 2025-01-31 |
| VIR-2218 and Peginterferon Alfa-2a for Chronic Hepatitis B (NCT06092333) | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 2025-01-31 |
| Single-Site Study of Naltrexone/Acetaminophen for the Acute Treatment of Migraine: A Phase 2 Randomized Trial (NCT05685225) | Allodynic Therapeutics, Inc | 2025-01-31 |
| Efficacy and Safety of Jia Shen Tablets in Chronic Heart Failure (NCT06669169) | Tasly Pharmaceutical Group Co., Ltd | 2025-01-31 |
| A Study of Dengue Tetravalent Vaccine (TDV) in Healthy Participants in Japan (NCT06741683) | Takeda | 2025-01-31 |
| A Phase 1/2a Study of WVE-007 in Adults Living With Overweight or Obesity (NCT06842186) | Wave Life Sciences USA, Inc. | 2025-01-31 |
| A Study of ONO-1110 in Patients With Social Anxiety Disorder (NCT06805565) | Ono Pharmaceutical Co., Ltd. | 2025-01-31 |
| Niraparib and Dostarlimab for Patients With MMR-D/MSI-H Colorectal Cancers (NCT06365970) | Ibrahim Halil Sahin | 2025-01-31 |
| Reduced-dose Conditioning Regimen Containing TBI in HSCT Treating Elderly Patients With Aplastic Anemia (NCT06769568) | Institute of Hematology & Blood Diseases Hospital, China | 2025-01-31 |
| Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma (NCT06803875) | Roberto Chiarle | 2025-01-31 |
| A Phase I/II Study of IVONESCIMAB in Recurrent Glioblastoma (NCT06672575) | M.D. Anderson Cancer Center | 2025-01-30 |
| Mechanistic Insights to Weight Loss Maintenance Through SGLT2 Inhibitors (NCT05885074) | University of Alabama at Birmingham | 2025-01-30 |
| A Study of AZD0486 Monotherapy or in Combination With Other Anti-Cancer Agents for Mature B-Cell Malignancies (NCT06564038) | AstraZeneca | 2025-01-30 |
| State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma (NCT06888128) | Baylor College of Medicine | 2025-01-30 |
| Search for Novel Transcranial Magnetic Stimulation (TMS) Targets for Mental Illness (NCT06376734) | Brigham and Women's Hospital | 2025-01-30 |
| Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis (NCT06374459) | Washington University School of Medicine | 2025-01-30 |
| Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures (NCT06713798) | Gustave Roussy, Cancer Campus, Grand Paris | 2025-01-30 |
| Paroxetine Versus Placebo for Vasomotor Symptom Management in Surgical Menopause (NCT06763484) | Universidad Nacional Autonoma de Honduras | 2025-01-30 |
| EBRT and HDR Brachytherapy for Unfavorable-intermediate, High, and Very High-risk Prostate Cancer (NCT04465500) | University of Virginia | 2025-01-30 |
| Venetoclax and Decitabine in R/R T-ALL (NCT06712121) | Seoul National University Hospital | 2025-01-30 |
| Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia (NCT06816134) | The First Affiliated Hospital of Soochow University | 2025-01-30 |
| Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS) (NCT06634875) | Buzzard Pharmaceuticals | 2025-01-30 |
| A Study to Investigate the Efficacy and Safety of Subcutaneous Lunsekimig (SAR443765) Compared With Placebo in Adult Participants With Moderate-to-severe Atopic Dermatitis (NCT06790121) | Sanofi | 2025-01-30 |
| GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma (NCT06522386) | M.D. Anderson Cancer Center | 2025-01-30 |
| Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression (NCT05774665) | Massachusetts General Hospital | 2025-01-30 |
| Assessment of Novel Metabolic Imaging Modalities as A Predictor Of Therapeutic EfficacyiIn Glioblastoma (GBM) (NCT06855628) | Stanford University | 2025-01-30 |
| Evaluation of the Safety of LipiodolⓇ Embolization in Symptomatic Digital Osteoarthritis Refractory to Conventional Treatment (NCT06611007) | University Hospital, Grenoble | 2025-01-30 |
| Belatacept in Heart Transplantation (NCT06478017) | National Institute of Allergy and Infectious Diseases (NIAID) | 2025-01-29 |
| Study of Anti-CEACAM5 ADC M9140 in Participants With Advanced Solid Tumors (PROCEADE PanTumor) (NCT06710132) | EMD Serono Research & Development Institute, Inc. | 2025-01-29 |
| Self-administration of Subcutaneous Elranatamab in the Patients' Homes. (NCT06015542) | Thomas Lund | 2025-01-29 |
| BAL Fluid Biomarkers in Sarcoma (NCT06815666) | University Health Network, Toronto | 2025-01-29 |
| A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy (NCT06797869) | Novo Nordisk A/S | 2025-01-29 |
| The Diagnostic Accuracy and Clinical Value of FAPI PET in Pleural Mesothelioma (NCT06790082) | Aalborg University Hospital | 2025-01-29 |
| A First-in-Human Trial of Safety and Efficacy of GEN1078 in Participants With Solid Tumors (NCT06771921) | Genmab | 2025-01-29 |
| A Study to Evaluate the Efficacy and Safety of CIN-102 (Deudomperidone) in Adult Subjects With Idiopathic Gastroparesis. (NCT06899217) | CinDome Pharma, Inc. | 2025-01-29 |
| Clinical Study on the Early Bactericidal Activity of Sitafloxacin Against Mycobacterium Abscessus Disease (NCT06809413) | Beijing Chest Hospital | 2025-01-28 |
| Study of Sunobinop on Craving in Alcohol Use Disorder (NCT06545929) | Knoa Pharma LLC | 2025-01-28 |
| Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients (NCT07724873) | Tata Memorial Centre | 2025-01-28 |
| Hyperbaric Oxygen Therapy on Insulin Resistance in Postmenopause (NCT06806345) | Cairo University | 2025-01-28 |
| Phase 2 Trial Evaluating the Efficacy and Safety of RBD5044 in Patients With Mixed Dyslipidemia (NCT06797401) | Ribocure Pharmaceuticals AB | 2025-01-28 |
| FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC (NCT06788990) | Bicara Therapeutics | 2025-01-28 |
| SARS-CoV-2 Safety Study for the Treatment of COVID-19 (NCT06489860) | DHA Coffee Co., Ltd | 2025-01-28 |
| Sotagliflozin in Patients With Heart Failure Symptoms and Type 1 Diabetes (NCT06435156) | University of Dundee | 2025-01-28 |
| An Open-Label Pilot Study of VTX2735 in Recurrent Pericarditis (NCT06836232) | Zomagen Biosciences Ltd. | 2025-01-28 |
| A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm (NCT06597734) | M.D. Anderson Cancer Center | 2025-01-28 |
| Efficacy and Safety of KBP-336 in Obese Individuals with Osteoarthritis (NCT06833749) | KeyBioscience AG | 2025-01-28 |
| Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients (NCT06780202) | Emory University | 2025-01-27 |
| Postsurgical Analgesia After Hernia Repair (NCT06709612) | AmacaThera Inc. | 2025-01-27 |
| Evaluation of Uterine Fibroids by CEUS and SHAPE Pre and Post UAE (NCT06705075) | Thomas Jefferson University | 2025-01-27 |
| Phase 1/2 Trial to Evaluate the Safety and Efficacy of PEEL-224 in Combination With Vincristine and Temozolomide in Adolescents and Young Adults With Relapsed or Refractory Sarcomas (NCT06709495) | David S Shulman, MD | 2025-01-27 |
| A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia (NCT06767683) | Alkermes, Inc. | 2025-01-27 |
| NEOadjuvant Abemaciclib and GIredestrant TriaL in Patients with ER-positive, HER2-negative Early Breast Cancer (NCT06259929) | Fondazione Oncotech | 2025-01-27 |
| SB17170 Phase 2 Trial in IPF Patients (NCT06747923) | SPARK Biopharma | 2025-01-27 |
| Interest of Post-operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour (NCT06524583) | UNICANCER | 2025-01-27 |
| Phase 2 Trial to Evaluate Safety and Immunogenicity of Inventprise's (IVT) 25-valent Pneumococcal Conjugate Vaccine (IVT PCV-25) in Healthy Infants (NCT06790290) | Inventprise Inc. | 2025-01-27 |
| Olverembatinib Combined With Venetoclax and Azacitidine in Blast Phase Ph Chromosome-positive CML (NCT06757855) | Institute of Hematology & Blood Diseases Hospital, China | 2025-01-26 |
| A Phase II Clinical Study to Evaluate HLX43 in Patients With Recurrent/Metastatic ESCC Failed or Intolerance to Standard Therapy (NCT06769113) | Shanghai Henlius Biotech | 2025-01-26 |
| Efficacy, Safety, and Pharmacokinetics of LP-003 Injection in Allergic Asthma Patients (NCT07342803) | Longbio Pharma | 2025-01-25 |
| The Impact of Ginger Mouthwash on the Pregnant Women With Stress and Gingivitis (NCT06792812) | Al-Mustansiriyah University | 2025-01-25 |
| Decreasing Treatment for Metastatic HER2-Positive Breast Cancer With Undectable Cancer Levels in Blood Tests. (NCT06450314) | UNICANCER | 2025-01-25 |
| Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A (NCT06802055) | Peking Union Medical College Hospital | 2025-01-25 |
| Neoadjuvant FOLFIRINOX and Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer Patients (NCT06812728) | Menoufia University | 2025-01-25 |
| Albumin-Bound Paclitaxel and Gemcitabine With or Without S-1 as First-Line Treatment for Advanced Pancreatic Cancer (NCT06789679) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-01-25 |
| A Single-arm, Multicenter, Prospective Phase II Clinical Study of Apatinib in Combination With Adebrelimab and EC Regimen in the First-line Treatment of Extensive Small Cell Lung Cancer (NCT06786312) | Fujian Cancer Hospital | 2025-01-25 |
| Efficacy of Plasmapheresis in Patients of Drug-Induced Liver Injury (DILI) With Underlying Chronic Liver Disease (NCT06797011) | Institute of Liver and Biliary Sciences, India | 2025-01-25 |
| A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults (NCT06761417) | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | 2025-01-24 |
| Atezolizumab and Rechallenge Chemotherapy in Relapsed Patients With Extensive-stage Small Cell Lung Cancer (ES-SCLC). (NCT06663098) | Gruppo Oncologico Italiano di Ricerca Clinica | 2025-01-24 |
| A Study of GlcNAc on Tear Production in NGLY1-CDDG (NCT05402345) | Eva Morava-Kozicz | 2025-01-24 |